Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.
Comments
0
Be the first to comment
Sign up now and become a member of the TheBrief.Health community!
Comments
0Be the first to comment
Sign up now and become a member of the TheBrief.Health community!